- REPORT SUMMARY
- TABLE OF CONTENTS
-
mRNA Vaccines & Therapeutics market report explains the definition, types, applications, major countries, and major players of the mRNA Vaccines & Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
In-Cell-Art
eTheRNA
CureVac
Translate Bio
Tiba Biotechnology
Moderna Therapeutics
Sangamo Therapeutics
Argos Therapeutics
Ethris
BioNTech
By Type:
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By End-User:
Infectious Disease
Cancer
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global mRNA Vaccines & Therapeutics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 mRNA Vaccines & Therapeutics Outlook to 2028- Original Forecasts
-
2.2 mRNA Vaccines & Therapeutics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term mRNA Vaccines & Therapeutics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global mRNA Vaccines & Therapeutics Market- Recent Developments
-
6.1 mRNA Vaccines & Therapeutics Market News and Developments
-
6.2 mRNA Vaccines & Therapeutics Market Deals Landscape
7 mRNA Vaccines & Therapeutics Raw Materials and Cost Structure Analysis
-
7.1 mRNA Vaccines & Therapeutics Key Raw Materials
-
7.2 mRNA Vaccines & Therapeutics Price Trend of Key Raw Materials
-
7.3 mRNA Vaccines & Therapeutics Key Suppliers of Raw Materials
-
7.4 mRNA Vaccines & Therapeutics Market Concentration Rate of Raw Materials
-
7.5 mRNA Vaccines & Therapeutics Cost Structure Analysis
-
7.5.1 mRNA Vaccines & Therapeutics Raw Materials Analysis
-
7.5.2 mRNA Vaccines & Therapeutics Labor Cost Analysis
-
7.5.3 mRNA Vaccines & Therapeutics Manufacturing Expenses Analysis
8 Global mRNA Vaccines & Therapeutics Import and Export Analysis (Top 10 Countries)
-
8.1 Global mRNA Vaccines & Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global mRNA Vaccines & Therapeutics Export by Region (Top 10 Countries) (2017-2028)
9 Global mRNA Vaccines & Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global mRNA Vaccines & Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Standardization Of Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
9.2 Global mRNA Vaccines & Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise mRNA Vaccines & Therapeutics Market Analysis and Outlook till 2022
-
10.1 Global mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.2.2 Canada mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.2.3 Mexico mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.2 UK mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.3 Spain mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.4 Belgium mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.5 France mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.6 Italy mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.7 Denmark mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.8 Finland mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.9 Norway mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.10 Sweden mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.11 Poland mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.12 Russia mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.3.13 Turkey mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4.2 Japan mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4.3 India mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4.4 South Korea mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4.5 Pakistan mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4.6 Bangladesh mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4.7 Indonesia mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4.8 Thailand mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4.9 Singapore mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4.10 Malaysia mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4.11 Philippines mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.4.12 Vietnam mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.5.2 Colombia mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.5.3 Chile mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.5.4 Argentina mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.5.5 Venezuela mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.5.6 Peru mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.5.7 Puerto Rico mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.5.8 Ecuador mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.6.2 Kuwait mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.6.3 Oman mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.6.4 Qatar mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.6.5 Saudi Arabia mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.6.6 United Arab Emirates mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.7.2 South Africa mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.7.3 Egypt mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.7.4 Algeria mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia mRNA Vaccines & Therapeutics Consumption (2017-2022)
-
10.8.2 New Zealand mRNA Vaccines & Therapeutics Consumption (2017-2022)
11 Global mRNA Vaccines & Therapeutics Competitive Analysis
-
11.1 In-Cell-Art
-
11.1.1 In-Cell-Art Company Details
-
11.1.2 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 In-Cell-Art mRNA Vaccines & Therapeutics Main Business and Markets Served
-
11.1.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 eTheRNA
-
11.2.1 eTheRNA Company Details
-
11.2.2 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 eTheRNA mRNA Vaccines & Therapeutics Main Business and Markets Served
-
11.2.4 eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 CureVac
-
11.3.1 CureVac Company Details
-
11.3.2 CureVac mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 CureVac mRNA Vaccines & Therapeutics Main Business and Markets Served
-
11.3.4 CureVac mRNA Vaccines & Therapeutics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Translate Bio
-
11.4.1 Translate Bio Company Details
-
11.4.2 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Translate Bio mRNA Vaccines & Therapeutics Main Business and Markets Served
-
11.4.4 Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Tiba Biotechnology
-
11.5.1 Tiba Biotechnology Company Details
-
11.5.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Main Business and Markets Served
-
11.5.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Moderna Therapeutics
-
11.6.1 Moderna Therapeutics Company Details
-
11.6.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Main Business and Markets Served
-
11.6.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Sangamo Therapeutics
-
11.7.1 Sangamo Therapeutics Company Details
-
11.7.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Main Business and Markets Served
-
11.7.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Argos Therapeutics
-
11.8.1 Argos Therapeutics Company Details
-
11.8.2 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Argos Therapeutics mRNA Vaccines & Therapeutics Main Business and Markets Served
-
11.8.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Ethris
-
11.9.1 Ethris Company Details
-
11.9.2 Ethris mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Ethris mRNA Vaccines & Therapeutics Main Business and Markets Served
-
11.9.4 Ethris mRNA Vaccines & Therapeutics Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 BioNTech
-
11.10.1 BioNTech Company Details
-
11.10.2 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 BioNTech mRNA Vaccines & Therapeutics Main Business and Markets Served
-
11.10.4 BioNTech mRNA Vaccines & Therapeutics Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global mRNA Vaccines & Therapeutics Market Outlook by Types and Applications to 2028
-
12.1 Global mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Standardization Of Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise mRNA Vaccines & Therapeutics Market Analysis and Outlook to 2028
-
13.1 Global mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.2.2 Canada mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.2.3 Mexico mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.2 UK mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.3 Spain mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.4 Belgium mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.5 France mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.6 Italy mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.7 Denmark mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.8 Finland mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.9 Norway mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.10 Sweden mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.11 Poland mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.12 Russia mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.3.13 Turkey mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4.2 Japan mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4.3 India mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4.4 South Korea mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4.8 Thailand mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4.9 Singapore mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4.11 Philippines mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.5.2 Colombia mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.5.3 Chile mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.5.4 Argentina mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.5.6 Peru mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.6.3 Oman mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.6.4 Qatar mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.7.2 South Africa mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.7.3 Egypt mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.7.4 Algeria mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand mRNA Vaccines & Therapeutics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of mRNA Vaccines & Therapeutics
-
Figure of mRNA Vaccines & Therapeutics Picture
-
Table Global mRNA Vaccines & Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global mRNA Vaccines & Therapeutics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Standardization Of Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Disease Treatment MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Infection Prevention MRNA Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global mRNA Vaccines & Therapeutics Consumption by Country (2017-2022)
-
Table North America mRNA Vaccines & Therapeutics Consumption by Country (2017-2022)
-
Figure United States mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Canada mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Mexico mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe mRNA Vaccines & Therapeutics Consumption by Country (2017-2022)
-
Figure Germany mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure UK mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Spain mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Belgium mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure France mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Italy mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Denmark mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Finland mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Norway mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Sweden mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Poland mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Russia mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Turkey mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Table APAC mRNA Vaccines & Therapeutics Consumption by Country (2017-2022)
-
Figure China mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Thailand mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Singapore mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Philippines mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Table South America mRNA Vaccines & Therapeutics Consumption by Country (2017-2022)
-
Figure Brazil mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Colombia mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Chile mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Argentina mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Peru mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Table GCC mRNA Vaccines & Therapeutics Consumption by Country (2017-2022)
-
Figure Bahrain mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Oman mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Qatar mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Africa mRNA Vaccines & Therapeutics Consumption by Country (2017-2022)
-
Figure Nigeria mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Africa mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Egypt mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Algeria mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Oceania mRNA Vaccines & Therapeutics Consumption by Country (2017-2022)
-
Figure Australia mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand mRNA Vaccines & Therapeutics Consumption and Growth Rate (2017-2022)
-
Table In-Cell-Art Company Details
-
Table In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table In-Cell-Art mRNA Vaccines & Therapeutics Main Business and Markets Served
-
Table In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
-
Table eTheRNA Company Details
-
Table eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table eTheRNA mRNA Vaccines & Therapeutics Main Business and Markets Served
-
Table eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
-
Table CureVac Company Details
-
Table CureVac mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table CureVac mRNA Vaccines & Therapeutics Main Business and Markets Served
-
Table CureVac mRNA Vaccines & Therapeutics Product Portfolio
-
Table Translate Bio Company Details
-
Table Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Translate Bio mRNA Vaccines & Therapeutics Main Business and Markets Served
-
Table Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
-
Table Tiba Biotechnology Company Details
-
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Main Business and Markets Served
-
Table Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
-
Table Moderna Therapeutics Company Details
-
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Main Business and Markets Served
-
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
-
Table Sangamo Therapeutics Company Details
-
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Main Business and Markets Served
-
Table Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
-
Table Argos Therapeutics Company Details
-
Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Argos Therapeutics mRNA Vaccines & Therapeutics Main Business and Markets Served
-
Table Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
-
Table Ethris Company Details
-
Table Ethris mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ethris mRNA Vaccines & Therapeutics Main Business and Markets Served
-
Table Ethris mRNA Vaccines & Therapeutics Product Portfolio
-
Table BioNTech Company Details
-
Table BioNTech mRNA Vaccines & Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioNTech mRNA Vaccines & Therapeutics Main Business and Markets Served
-
Table BioNTech mRNA Vaccines & Therapeutics Product Portfolio
-
Figure Global Standardization Of Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Individualized Cancer Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Disease Treatment MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infection Prevention MRNA Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global mRNA Vaccines & Therapeutics Consumption Forecast by Country (2022-2028)
-
Table North America mRNA Vaccines & Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe mRNA Vaccines & Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Germany mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC mRNA Vaccines & Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure China mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America mRNA Vaccines & Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Brazil mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC mRNA Vaccines & Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa mRNA Vaccines & Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania mRNA Vaccines & Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Australia mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand mRNA Vaccines & Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-